Ligand validation:4LM6

DBV: 15,16-DIHYDROBILIVERDIN

DBV is a Ligand Of Interest in 4LM6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4LM6_DBV_B_201	93%	12%	0.064	0.96	2.61	1.53	10	8	0	0	100%	1
4LM6_DBV_D_201	93%	11%	0.065	0.959	2.71	1.55	10	8	0	0	100%	1
7S96_DBV_D_201	84%	24%	0.082	0.944	1.7	1.43	6	6	0	0	100%	1
7S97_DBV_D_201	62%	24%	0.147	0.938	1.73	1.38	8	7	1	0	100%	1
4LMS_DBV_D_201	96%	15%	0.058	0.969	2.35	1.44	9	8	0	0	100%	1
7TJA_DBV_I_101	92%	22%	0.071	0.96	1.58	1.68	9	11	0	0	100%	1
4LMX_DBV_F_201	88%	10%	0.078	0.953	2.82	1.52	10	6	0	0	100%	1
6QX6_DBV_B_501	86%	38%	0.082	0.951	1.3	1.15	4	3	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.